Cambridge, Mass. – September 13, 2026 -- Marengo Therapeutics has completed enrollment in the monotherapy cohorts of its Phase 1/2 STARt-001 trial evaluating invikafusp alfa across eight distinct PD-1-resistant tumor types, with updated results selected for an oral presentation at the ESMO 2026 Congress in Madrid, October 23-27.

Bethesda, Md. – September 13, 2026 -- Centrus Energy Corp. [NYSE: LEU] has signed a definitive multi-year contract to supply high-assay, low-enriched uranium (HALEU) to Radiant, adding a new domestic fuel customer as deliveries are set to begin before the end of the decade.

Ft. Lauderdale – September 13, 2026 -- Z Squared Inc. (Nasdaq: ZSQR) closed its all-stock acquisition of Paradox Data, LLC, gaining an energized computing campus in El Dorado, Arkansas, with an existing 8.0 MW electric service arrangement and a phased target of 150+ MW of AI-ready capacity.

Chicago – September 13, 2026 -- Alliant Credit Union, a $20 billion-asset institution with nearly 1 million members, has partnered with Blend Labs Inc. (NYSE: BLND) to launch a fully digital mortgage and home equity lending platform.

London and New York – September 13, 2026 -- Coinbase has selected ION's XTP for Event Contracts platform to handle clearing for Kalshi, the world's largest prediction market, as trading volumes in event-based contracts accelerate.

Boulder, Colo. – September 13, 2026 -- Integral Consulting Inc. has acquired Heritage Environmental Consultants, a Western U.S.-based environmental planning, permitting, and scientific services firm, expanding its footprint in the Mountain West region.

Tucson – September 13, 2026 -- Delta Development Team (DDT) has launched BloodCOMM®, a cloud-based blood management platform designed to digitize and automate blood supply chain tracking for hospitals, blood centers, EMS agencies, and air medical providers.

Dallas – September 13, 2026 -- The U.S. Food and Drug Administration has accepted and filed the Biologics License Application for MOGENRY, an optogenetic gene therapy from Nanoscope Therapeutics designed to restore vision in retinitis pigmentosa patients with severe vision loss. If approved, MOGENRY would become the first gene-agnostic treatment available for this patient population, which currently has no approved therapy.

Jacksonville, Fla. – September 13, 2026 -- Alan Alwakeel, a recent graduate of Stanton College Preparatory School, received a $3,000 Humane Science Award from the National Anti-Vivisection Society (NAVS) for an AI-powered cancer therapy simulation platform that eliminates the need for animal testing.

North Billerica, Mass. – September 13, 2026 -- Mass-Vac, Inc. has launched the MV Multi-Trap® Vacuum Inlet Trap, a high-capacity filtration unit for plastic extrusion lines that is field-proven to extend vacuum pump life by more than 12 years.